D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 80 Citations 34,135 245 World Ranking 660 National Ranking 27
Medicine D-index 87 Citations 37,707 351 World Ranking 7018 National Ranking 195

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Asthma
  • Gene

Pascal Chanez spends much of his time researching Asthma, Immunology, Internal medicine, Respiratory disease and COPD. His studies in Asthma integrate themes in fields like Physical therapy, Severity of illness and Randomized controlled trial. He combines subjects such as Chronic bronchitis and Bronchoalveolar lavage with his study of Immunology.

His Internal medicine research includes themes of Placebo, Surgery, Airway and Endocrinology. The study incorporates disciplines such as Mepolizumab and Exacerbation in addition to Placebo. Pascal Chanez has included themes like Lipoxin, Biopsy, Immunopathology, Monoclonal antibody and Eicosanoid in his Respiratory disease study.

His most cited work include:

  • Eosinophilic inflammation in asthma. (2261 citations)
  • International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma (1799 citations)
  • Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial. (1306 citations)

What are the main themes of his work throughout his whole career to date?

His main research concerns Asthma, Immunology, Internal medicine, COPD and Inflammation. His Asthma study combines topics in areas such as Respiratory disease, Airway, Cohort and Intensive care medicine. The concepts of his Intensive care medicine study are interwoven with issues in Disease and MEDLINE.

His Immunology research includes elements of Sputum and Bronchoalveolar lavage, Lung. Pascal Chanez interconnects Gastroenterology, Placebo, Endocrinology and Physical therapy in the investigation of issues within Internal medicine. The various areas that he examines in his Placebo study include Mepolizumab and Adverse effect.

He most often published in these fields:

  • Asthma (44.50%)
  • Immunology (36.70%)
  • Internal medicine (33.26%)

What were the highlights of his more recent work (between 2017-2021)?

  • Internal medicine (33.26%)
  • Asthma (44.50%)
  • Immunology (36.70%)

In recent papers he was focusing on the following fields of study:

Pascal Chanez mostly deals with Internal medicine, Asthma, Immunology, Severe asthma and Cohort. His Internal medicine research incorporates elements of Gastroenterology and Placebo. Pascal Chanez studies Asthma, focusing on Endotype in particular.

In his study, which falls under the umbrella issue of Immunology, Eosinophil is strongly linked to Sputum. His work on Bronchial thermoplasty as part of his general Severe asthma study is frequently connected to In patient, thereby bridging the divide between different branches of science. Pascal Chanez works mostly in the field of Cohort, limiting it down to topics relating to COPD and, in certain cases, Cardiology and Mortality rate.

Between 2017 and 2021, his most popular works were:

  • Management of severe asthma: a European Respiratory Society/American Thoracic Society guideline (104 citations)
  • Protein crystallization promotes type 2 immunity and is reversible by antibody treatment. (69 citations)
  • Epithelial IL-6 trans-signaling defines a new asthma phenotype with increased airway inflammation (61 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Gene
  • Asthma

His scientific interests lie mostly in Asthma, Internal medicine, Eosinophil, Immunology and Severe asthma. His study on Asthma also encompasses disciplines like

  • MEDLINE which intersects with area such as Tertiary care and Guideline,
  • Randomized controlled trial most often made with reference to Intensive care medicine. His Internal medicine study incorporates themes from Gastroenterology and Placebo.

His work carried out in the field of Eosinophil brings together such families of science as Mast cell, Inflammation, Immune system and Respiratory system. Pascal Chanez combines subjects such as Sputum, Transcription factor, Disease and Lung with his study of Immunology. His work on Bronchial thermoplasty as part of general Severe asthma study is frequently linked to Breath gas analysis, bridging the gap between disciplines.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Eosinophilic inflammation in asthma.

J Bousquet;P Chanez;J Y Lacoste;G Barnéon.
The New England Journal of Medicine (1990)

3092 Citations

International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma

Kian Fan Chung;Sally E. Wenzel;Jan L. Brozek;Andrew Bush.
European Respiratory Journal (2014)

2805 Citations

Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial.

Ian D Pavord;Stephanie Korn;Peter Howarth;Eugene R Bleecker.
The Lancet (2012)

1795 Citations

Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma

Hector G. Ortega;Mark C. Liu;Ian D. Pavord;Guy G. Brusselle.
The New England Journal of Medicine (2014)

1551 Citations

An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice.

Helen K. Reddel;D. Robin Taylor;Eric D. Bateman;Louis-Philippe Boulet.
American Journal of Respiratory and Critical Care Medicine (2009)

1251 Citations

Induction of nitric oxide synthase in asthma

Q Hamid;Springall;JM Polak;V Riveros-Moreno.
The Lancet (1993)

1011 Citations

Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial

Eugene R Bleecker;J Mark FitzGerald;Pascal Chanez;Alberto Papi.
The Lancet (2016)

859 Citations

Transforming Growth Factor- β Expression in Mucosal Biopsies in Asthma and Chronic Bronchitis

A M Vignola;P Chanez;G Chiappara;A Merendino.
American Journal of Respiratory and Critical Care Medicine (1997)

721 Citations

Withdrawal of Inhaled Glucocorticoids and Exacerbations of COPD

Helgo Magnussen;Bernd Disse;Roberto Rodriguez-Roisin;Anne Kirsten.
The New England Journal of Medicine (2014)

652 Citations

A new perspective on concepts of asthma severity and control

D. R. Taylor;E. D. Bateman;L.-P. Boulet;H. A. Boushey.
European Respiratory Journal (2008)

579 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Pascal Chanez

Peter J. Barnes

Peter J. Barnes

Imperial College London

Publications: 202

Kian Fan Chung

Kian Fan Chung

National Institutes of Health

Publications: 188

Peter G. Gibson

Peter G. Gibson

University of Newcastle Australia

Publications: 165

Sally E. Wenzel

Sally E. Wenzel

University of Pittsburgh

Publications: 149

Ian D. Pavord

Ian D. Pavord

University of Oxford

Publications: 146

Jean Bousquet

Jean Bousquet

Inserm : Institut national de la santé et de la recherche médicale

Publications: 142

Giorgio Walter Canonica

Giorgio Walter Canonica

Humanitas University

Publications: 135

Christopher E. Brightling

Christopher E. Brightling

University of Leicester

Publications: 132

Ian M. Adcock

Ian M. Adcock

National Institutes of Health

Publications: 129

David Price

David Price

University of Aberdeen

Publications: 120

William W. Busse

William W. Busse

University of Wisconsin–Madison

Publications: 112

Claus Bachert

Claus Bachert

Ghent University

Publications: 112

Guy Brusselle

Guy Brusselle

Ghent University Hospital

Publications: 109

Eugene R. Bleecker

Eugene R. Bleecker

University of Arizona

Publications: 101

Stephen T. Holgate

Stephen T. Holgate

University of Southampton

Publications: 99

Alberto Papi

Alberto Papi

University of Ferrara

Publications: 98

Trending Scientists

Phil Blunsom

Phil Blunsom

Google (United States)

Joelle Pineau

Joelle Pineau

McGill University

Cem Ersoy

Cem Ersoy

Boğaziçi University

Young-Kai Chen

Young-Kai Chen

Nokia (United States)

Simon M. Landhäusser

Simon M. Landhäusser

University of Alberta

Nikolay V. Dokholyan

Nikolay V. Dokholyan

Pennsylvania State University

Kate L Loveland

Kate L Loveland

Hudson Institute of Medical Research

Robert A. Nicholas

Robert A. Nicholas

University of North Carolina at Chapel Hill

Michael B. Robinson

Michael B. Robinson

Children's Hospital of Philadelphia

Arthur F. McGarr

Arthur F. McGarr

United States Geological Survey

David Stevenson

David Stevenson

University of Edinburgh

Florian Mormann

Florian Mormann

University of Bonn

L. Alan Sroufe

L. Alan Sroufe

University of Minnesota

John T. Fallon

John T. Fallon

East Carolina University

Jacqueline K. Faherty

Jacqueline K. Faherty

American Museum of Natural History

Martha P. Haynes

Martha P. Haynes

Cornell University

Something went wrong. Please try again later.